Archive for the ‘Artificial Intelligence’ Category

Cleveland Clinic, NFLPA to use artificial intelligence to improve diagnosis and treatment of neurological dis – cleveland.com

CLEVELAND, Ohio The Cleveland Clinic and the NFL Players Association are working together to use artificial intelligence and machine learning to improve the diagnosis of neurological diseases and guide treatment, the health system and players union announced Tuesday.

The joint initiative seeks to use technology to identify neurological diseases like Parkinsons and Alzheimers and determine how they might progress. The goal is to use artificial intelligence and machine learning to inform interventions and treatment, said principal investigator Dr. Jay Alberts from the Clinics Lerner Research Institute. Alberts is also vice chair for innovation for the Clinics Neurological Institute.

The opportunity we have here is that were going to be looking at a tremendous amount of data, Alberts said. By looking at all of that data and then using machine learning we are going to be able to work together and create these interesting, impactful models.

The Clinic/NFLPA initiative will use data from 60,000 of the Clinics neurological patients, who will remain anonymous, to develop algorithms related to cognitive impairment. The goal is to use the technology and a patients short-term clinical data to predict their long-term outlook.

The research will provide insight for prevention and treatment programs for current and former football players, the news release says.

This partnership with Cleveland Clinic is an exciting extension of our unions ongoing commitment to advancing the physical and mental health of our player members, NFLPA Executive Director DeMaurice Smith said in the news release. As the physician community learns more about neurological disease through the resulting clinical decision-support tools, the better informed we will be in providing education and safety initiatives for professional football players.

Artificial intelligence refers to a collection of technologies, and experts believe they have the potential to improve health care. One type of AI called machine learning uses algorithms to find patterns in large amounts of data. It can use those patterns to make predictions -- for example, Spotify uses machine learning to recommend a song you might like based on other songs youve listened to previously.

That could mean better treatment for patients. For example, Clinic researchers are currently studying whether aerobic exercise could slow the progression of Parkinsons. If AI and machine learning could help diagnose Parkinsons early on, physicians could prescribe a specific exercise regimen to help the patient, Alberts said.

We can actually start using different interventions or different approaches, and be much more prescriptive, Alberts said.

The partners also envision the models being used to help provide better health care in rural and underserved communities. A doctor in a rural area may see only three or four Parkinsons patients, but the project could provide valuable insights into how to treat them, Alberts said.

The Clinic and NFLPA also plan to work with other partners to create a research network to evaluate and create phased research projects. The network will publish any request for proposals for further projects that could further advance the understanding of neurological diseases and their progression.

Were hoping we can attract others universities, or even startups or established companies, to come in and work with us on data sets, or even bring new data to the table, and think about how we can create better and stronger models, Alberts said.

For years, studies have focused on the risk of neurological disease that football players face through brain injuries such as concussions. A 2012 study from the U.S. Centers for Disease Control and Prevention found NFL players are at a higher risk of death from brain diseases like Parkinsons, Alzheimers and ALS.

The effort is not focusing on chronic traumatic encephalopathy (CTE), the degenerative brain disease that has been linked to brain injuries that occur in football and other contact sports. That is due to the fact there is less available data on CTE, and AI and machine learning improve with large amounts of data, Alberts said.

The rest is here:
Cleveland Clinic, NFLPA to use artificial intelligence to improve diagnosis and treatment of neurological dis - cleveland.com

RIT researchers helping to develop artificial intelligence systems capable of playing ‘Starcraft II’ | RIT – RIT University News Services

A team of Rochester Institute of Technology researchers that develops artificial intelligence systems capable of learning over time is putting its work to a unique new test: creating machines capable of playing the popular video game Starcraft II. While tasking artificial intelligence with playing a science fiction strategy game may seem odd at first glance, researchers think it could be an important stepping stone to advancing practical solutions such as self-driving cars, service robots, and other real-world applications.

Christopher Kanan, an assistant professor at RITs Chester F. Carlson Center for Imaging Science, received nearly $210,000 from the Defense Advanced Research Projects Agency (DARPA) to work on phase two of the Lifelong Learning Machines (L2M) program this year. After having success with their research in phase one of the L2M, Kanan and his team were selected to work on this new project led by SRI International and includes collaborators from American University and Georgia Tech.

: A. Sue Weisler

Assistant Professor Christopher Kanan, left, and imaging science Ph.D. student Tyler Hayes, right, discuss artificial neural networks in this photo taken in 2018.

Kanan specializes in artificial neural networkscomputing systems inspired by the biological neural networks that make up human brains which have distinct advantages over many of the artificial intelligence systems used today. Current systems are typically built using training sets to master tasks and deployed to perform that task in perpetuity, but cannot learn new tasks on the fly without suffering from a problem called catastrophic forgetting. Kanan has built systems that can learn more organically by mimicking elements of the human brain, which will be helpful for the task at hand.

The system needs to learn how to play the game and retain information about skills it learns along the way, said Kanan. One thing that we are responsible for integrating into SRIs system is teaching it to learn very quickly to avoid bad outcomes. Our human brains have a region called the amygdala thats specifically responsible for learning fear, so we are trying to integrate specific modules for learning aversion into the system.

Kanan said another benefit of the neural networks he is developing is that they are far more computationally efficient. Many current artificial intelligence systems require vast amounts of computing power and electricity to operate, placing a toll on budgets and the environment.

The grant from DARPA will help fund three RIT graduate students to work on the project over the next year, including Tyler Hayes, an imaging science Ph.D. student from Buffalo, N.Y. She said she is excited to work on the project because catastrophic forgetting presents a major obstacle for artificial intelligence systems and the team is pioneering novel approaches to solve the problem.

I think its an important problem we need to be thinking about, especially in todays day and age, said Hayes. Traditional networks that need to be trained offline and cache all the data in a server might be OK in some applications, but when you deploy a lot of these systems in real-time, you want them to be able to adapt to their environment and change. Im excited that our lab is working on some of the biggest current challenges for continual learning including image classification, object detection, and visual question answering. Its going to make these systems much more applicable in real world scenarios.

View post:
RIT researchers helping to develop artificial intelligence systems capable of playing 'Starcraft II' | RIT - RIT University News Services

Artificial Intelligence in Genomics Market worth $1,671 million by 2025 – Exclusive Report by MarketsandMarkets – PRNewswire

CHICAGO, March 11, 2021 /PRNewswire/ -- According to the new market research report "Artificial Intelligence In Genomics Market by Offering (Software, Services),Technology (Machine Learning, Computer Vision), Functionality (Genome Sequencing, Gene Editing), Application (Diagnostics), End User (Pharma, Research) - Global Forecasts to 2025", published by MarketsandMarkets, the global AI in Genomics market is projected to reach USD 1,671 million by 2025 from USD 202 million in 2020, at a CAGR of 52.7% between 2020 and 2025

Browse in-depth TOC on "Artificial Intelligence in Genomics Market"141 Tables24 Figures 154 Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=36649899

The need to control drug development and discovery costs and time, increasing public and private investments in AI in genomics, and the adoption of AI solutions in precision medicine are driving the growth of this market. However, the lack of a skilled AI workforce and ambiguous regulatory guidelines for medical software are expected to restrain the market growth during the forecast period.

Machine learning to dominate the AI in Genomics market in 2019

Based on technology, the Artificial Intelligence in GenomicsMarket is segmented into machine learning and other technologies. The machine learning segment dominated this market in 2019, as pharmaceutical companies, CROs, and biotechnology companies have widely adopted machine learning for drug genomics applications. This is because machine learning can extract insights from data sets, accelerating genomic research.

Diagnostics segment accounted for the largest share of the AI in Genomics market, by end user, in 2019

Based on application, the Artificial Intelligence in GenomicsMarket is segmented into diagnostics, drug discovery & development, precision medicine, agriculture & animal research, and other applications. Diagnostics was the largest application segment in genomics market in 2019. The large share of this segment can be attributed to the increasing research on diseases and the decreasing cost of sequencing.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=36649899

North America is the largest regional market for AI in Genomics in 2019

In 2019, North America accounted for the largest share of the AI in Genomics market, followed by Europe. The large share of North America can be attributed to the increasing research funding and government initiatives for promoting precision medicine in the US.

Prominent players in the Artificial Intelligence in GenomicsMarket are IBM (US), Microsoft (US), NVIDIA Corporation (US), Deep Genomics (Canada), BenevolentAI (UK), Fabric Genomics Inc. (US), Verge Genomics (US), Freenome Holdings, Inc. (US), MolecularMatch Inc. (US), Cambridge Cancer Genomics (UK), SOPHiA GENETICS (US), Data4Cure Inc. (US), PrecisionLife Ltd (UK),Genoox Ltd. (US), Lifebit (UK), Diploid (Belgium), FDNA Inc. (US), DNAnexus Inc. (US), Empiric Logic (Ireland), Engine Biosciences Pte. Ltd. (US)

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=36649899

Browse Adjacent Markets: Healthcare IT Market ResearchReports & Consulting

Browse Related Reports:

Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024https://www.marketsandmarkets.com/Market-Reports/ai-in-drug-discovery-market-151193446.html

Genomics Market by Product & Service (System & Software, Consumables, Services), Technology (Sequencing, PCR), Application (Drug Discovery & Development, Diagnostic, Agriculture), End User (Hospital & Clinics, Research Centers) Global Forecast to 2025https://www.marketsandmarkets.com/Market-Reports/genomics-market-613.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:Mr. Aashish MehraMarketsandMarkets INC.630 Dundee RoadSuite 430Northbrook, IL 60062USA: +1-888-600-6441Email: [emailprotected]Research Insight: https://www.marketsandmarkets.com/ResearchInsight/artificial-intelligence-in-genomics-market.aspVisit Our Web Site: https://www.marketsandmarkets.comContent Source: https://www.marketsandmarkets.com/PressReleases/artificial-intelligence-in-genomics.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

SOURCE MarketsandMarkets

Original post:
Artificial Intelligence in Genomics Market worth $1,671 million by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire

Using Artificial Intelligence to Assess Breast Cancer – Chicago Health

Software that uses artificial intelligence (AI) may help improve breast cancer diagnosis.

QuantX, developed in Chicago, uses AI to analyze breast MRIs. Radiologists can use the technology to help assess if breast lesions are cancerous. Research shows the technology led to a 39% reduction in missed cancers, according to a clinical trial.

Maryellen Giger, PhD, a professor of radiology at the University of Chicago, developed the technology, which the FDA cleared in 2017. You can think of breast cancer screening as Wheres Waldo? she says, referring to the puzzle books where one searches for a character who blends in with background images.

QuantX, now owned by Chicago-based company Qlarity Imaging, generates a 3-D image that radiologists can rotate to see the size and location of a tumor. They can use that image to decide whether to conduct a biopsy.

Though patients are unlikely to know if a doctor used the software, its now in hospitals and imaging centers around the country. Down the line, similar software could be used to diagnose other cancers, like in the prostate and lung.

Susan Cosier is a Chicago-based writer focused on science and the environment. Her work has appeared in Scientific American and Science.

Continued here:
Using Artificial Intelligence to Assess Breast Cancer - Chicago Health

Covid-19 driven advances in automation and artificial intelligence risk exacerbating economic inequality – The BMJ

Anton Korinek and Joseph E Stiglitz make the case for a deliberate effort to steer technological advances in a direction that enhances the role of human workers

The covid-19 pandemic has necessitated interventions that reduce physical contact among people, with dire effects on our economy. By some estimates, a quarter of all jobs in the economy require physical interaction and are thus directly affected by the pandemic. This is highly visible in the medical sector, where workers and patients often come into close contact with each other and risk transmitting disease. In several countries medical workers have experienced some of the highest incidences of covid-19. Moreover, as patients were advised to postpone non-essential visits and procedures, medical providers in many countries have also experienced tremendous income losses.1

In economic language, covid-19 has added a shadow cost on labour that requires proximity. This shadow cost reflects the dollar equivalent of all the costs associated with the increased risk of disease transmission, including the costs of the adaptations required for covid-19. It consists of losses of both quality adjusted life days from increased morbidity and quality adjusted life years from increased mortality, as well as the cost of measures to reduce these risks, such as extra protective equipment and distancing measures for workers. Some sectors will incur increased costs from changing the physical arrangements in which production and other interactions occur so that there can be social distancing. It is, of course, understandable that we take these measures to reduce the spread of the disease: by some estimates, the social cost of one additional case of covid-19 over the course of the pandemic is $56000 (40000; 46000) to $111000.2

This shadow cost on labour is also accelerating the development and adoption of new technologies to automate human work. One example is the increasing use of telemedicine. Telemedicine is currently provided in a way that changes the format of delivery of care but leaves the role of doctors largely unchanged. However, it reduces the need for workers who provide ancillary services and who typically have lower wages than doctorsfor example, front office or cleaning staffthus increasing inequality. Moreover, going forward, it may also make it possible to provide medical services from other countries, which has hitherto been difficult, and hence reduce demand for doctors in high income countries.3

Complementary investments, for example internet connected devices such as thermometers, fingertip pulse oximeters, blood pressure cuffs, digital stethoscopes, and electrocardiography devices could further revolutionise the delivery of medical care and may also reduce demand for nurses.45 Such technologies have already made it possible to establish virtual wards for patients with covid-19.6 But even once covid-19 is controlled, medical providers will take into account the risk of future pandemics when choosing which technologies to invest in. Looking further ahead, technologies powered by artificial intelligence (AI), such as Babylon Healths chatbot, foreshadow a possible future in which medical functions traditionally done by doctors may also be automated. This would reduce labour demand and generate a whole new set of potential problems.7

In the past, cybersecurity risks such as computer viruses have held back automation, especially in the medical sector, in which privacy and security are of particular concern. It is ironic that a human virus is now levelling the playing field and forcing automation because it has lessened the appetite for employing humans.

These developments have the potential to reduce labour demand and wages across the economy, including in healthcare. However, making labour redundant is not inevitable. Technological progress in AI and related fields can be steered so that the benefits of advances in technology are widely shared.

The fear of job losses has accompanied technological progress since the Industrial Revolution.8 The history of progress has been one of relentless churning in the labour market, whereby progress made old jobs redundant and created new ones. This churning has always been painful for displaced workers, but economists used to believe that the new jobs created by progress would be pay better than the ones that became redundant so that progress would make workers better off on balance, once they had gone through the adjustment.9

The most useful way to analyse the effects of a new technology on labour markets is not to look at whether it destroys jobs in the short termmany technologies have done so, even though they turned out to be beneficial for workers in the long run. Instead, it is most useful to categorise the effects of technological progress according to whether they are labour using or labour savingthat is, whether they increase or decrease overall demand for labour at given wages and prices. For example, automating many of the processes involved in medical consultations, as in the example of telemedicine, is likely to be labour saving, whereas new medical treatments to improve patients health are likely to be labour using if they are performed by humans.10 In the long run, as markets adjust, changes in labour demand are mainly reflected in wages not in the number of jobs created or lost.

Overall, technological progress since the Industrial Revolution has been labour usingit increased labour demand by leaps and bounds, leading to a massive increase in average wages and material wealth in advanced countries. The reason was that innovation has increased the productivity of workersmaking them able to produce more per hourrather than replacing labour with robots.

However, more recently, the economic picture has been less benign: a substantial proportion of workers in the USfor example, production and non-supervisory workersearn lower wages now (when adjusted for inflation) than in the 1970s.11 Moreover, although it is not clear whether this finding holds in the rest of the world, the share of economic output in the US going to workers rather than the owners of capital has declined from 65% to less than 60% over the past half century.1213 Lower skilled workers have been the most affected. Many recent automation technologies have displaced human workers from their jobs in a way that reduced overall demand for human labour.14

Advances in AI may contribute to more shared prosperity,6 but there is also a risk that they accelerate the trend of the past four decades. The defining attribute of AI is to automate the last domain in which human workers had a comparative advantage over machinesour thinking and learning.15 And if the covid-19 pandemic adds extra incentives for labour saving innovation, the economic effects would be even more painful than in past episodes of technological progress. When the economy is expanding and progress is biased against labour, workers may still experience modest increases in their incomes even though the relative share of output that they may earn is declining. However, at a time when economic output across the globe is falling because of the effects of covid-19, a decline in the relative share of output earned by workers implies that their incomes are falling at faster rates than the rest of the economy. And unskilled manual workers who are at the lower rungs of the earnings distribution are likely to be most severely affected.

An additional aspect of digital technologies such as AI is that they generate what is often called a superstar phenomenon, which may lead to further increases in inequality. Digital technologies can be deployed at almost negligible cost once they have been developed.16 They therefore give rise to natural monopolies, leading to dominant market positions whereby superstar firms serve a large fraction of the marketeither because they are better than any competitors or because no one even attempts to duplicate their efforts and compete. These superstar effects are well known from entertainment industries. In the music industry, for example, the superstars have hundreds of millions of fans and reap in proportionate rewards, but the incomes of musicians further down the list decline quickly. Most of the rewards flow to the top. And empirical work documents that these superstar effects have played an important role in the rise in inequality in recent decades.17

A similar mechanism may soon apply in medicine, accelerated by the covid-19 pandemic. A commonly cited example is radiology. If one of the worlds top medical imaging companies develops an AI system that can read and robustly interpret mammograms better than humans, it would become the superstar in the sector and would displace the task of reading mammograms for thousands of radiologists. Since the cost of processing an additional set of images is close to zero, any earnings after the initial investment in the system has been recouped would earn high profit margins, and the company is likely to reap substantial economic benefits, at least as long as its intellectual property is protected by patents or trade secrets. (The design of the intellectual property regime is an important determinant of the extent of the inequality generated by the economic transformations discussed here.) The more widespread such diagnostic and decision making tools become, the more the medical sector will turn into a superstar industry.

Economic forces are continuing to drive rapid advances in AI, and covid-19 is adding strong tailwinds to these forces. The task now is to shape the forms that these advances will take to ensure that their effect on both patients and medical workers is desirable. The stakes are high since the choices that we make now will have long lasting effects.

We have a good sense of what happens at one extreme: if the direction of progress is determined purely by market forces without regard for shared human wellbeing, our technological future will be shaped by the shortcomings and failures of the market.1518

Markets may provide a force towards efficiency but are blind to distributional concerns, such as the deleterious consequences of labour saving progress or the superstar phenomenon. Responsible decision makers should pursue technologies that maintain an active role for humans and preserve a role for medical workers of all educational levels. For example, medical AI systems can be designed to be human centred tools that provide decision support or they can be designed to automate away human tasks.19 They should also focus on providing high quality care and value to patients with limited financial means rather than just serving patients according to their ability to pay.

Market failures are pervasive in both innovation and healthcare, and even more so at the intersection of the two. Markets encourage incremental advances that may not provide much value to society. They do not adequately provide incentives for larger scale breakthroughs that are most socially beneficial. And as the covid-19 pandemic has shown, they undervalue the benefits of preventive actions, including preventive actions against small probability but existential risks.

Market failures are sometimes exacerbated by government policies, which increase the cost of labour relative to capital, disadvantaging humans relative to machines. Examples include the low taxes on capital (especially capital gains) relative to labour and the artificially low interest rates that have prevailed since the 2008 financial crisis (although low interest rates are also boosting aggregate demand, which is beneficial for workers).

Our institutions and norms interact in important ways with market incentives for technological progress. Most visibly, our system of intellectual property rights, by providing temporary monopoly power to inventors, is meant to facilitate innovation. But often it has the opposite effectinhibiting access to existing knowledge and making the production of new ideas more difficult. Moreover, by inhibiting competition, both innovation and access to the benefits of the advances that occur are reduced. These are arguments for keeping the scope and length of intellectual property rights limited.

Finally, markets are inherently bad at delivering the human element that is so important in medical care. Markets do not adequately reward the empathy and compassion that medical workers provide to their patients and, in fact, provide incentives to scrimp on them. If our technological choices are driven solely by the market, they will reflect the same bias and patient care is likely to be affected. It is essential that decision makers act to ensure that our technological choices reflect our human values.20

The covid-19 pandemic has increased the risk and raised the cost of direct physical contact between humans, as is particularly visible in healthcare

This has accelerated advances in AI and other forms of automation to decrease physical contact and mitigate the risk of disease transmission

These technological advances benefit technologists but could reduce labour demand more broadly and slow wage growth, increasing inequality between workers and the owners of technology

These forces can be counteracted by intentionally steering technological progress in AI to complement labour, increasing its productivity

Contributors and sources: AK and JES wrote this article jointly by invitation from Sheng Wu at WHO. The two have collaborated on a series of papers investigating the effects of advances in AI on economic inequality, on which this analysis is based. All authors edited the manuscript before approving the final version. AK is guarantor.

Competing interests: We have read and understood BMJ policy on declaration of interests and have the following interests to declare: AK and JES are supported by a grant from the Institute for New Economic Thinking. AK serves as a senior adviser to the Partnership on AIs shared prosperity initiative working on related topics. JES is chief economist and senior fellow at the Roosevelt Institute working on a related theme.

Provenance and peer review: Commissioned; externally peer reviewed.

This collection of articles was proposed by the WHO Department of Digital Health and Innovation and commissioned by The BMJ. The BMJ retained full editorial control over external peer review, editing, and publication of these articles. Open access fees were funded by WHO.

This is an Open Access article distributed under the terms of the Creative Commons Attribution IGO License (https://creativecommons.org/licenses/by-nc/3.0/igo/), which permits use, distribution, and reproduction for non-commercial purposes in any medium, provided the original work is properly cited.

Korinek A. Labor in the age of automation and AI. Policy brief. Economists for Inclusive Prosperity, 2019.

Korinek A, Ng DX. Digitization and the macro-economics of superstars. Working paper. University of Virginia, 2019.

Korinek A, Stiglitz JE. Steering technological progress. Working paper. University of Virginia, 2021.

Read more from the original source:
Covid-19 driven advances in automation and artificial intelligence risk exacerbating economic inequality - The BMJ